二级市场创新药领域的蓬勃发展态势,愈发凸显出CXO行业的相对黯淡。今年上半年,创新药出海交易成绩斐然,总金额已逼近500亿美元,首付款超20亿美元,按照当前趋势,全年交易规模极有可能突破历史纪录。与2020—2024年相比,这一数据呈现出爆发式增长态势。彼时,BD交易总金额从92亿美元攀升至523亿美元,首付款总额也从6亿美元增长到41亿美元。创新药领域的这种价值重估,在二级市场获得了积极反馈。自...
Source Link二级市场创新药领域的蓬勃发展态势,愈发凸显出CXO行业的相对黯淡。今年上半年,创新药出海交易成绩斐然,总金额已逼近500亿美元,首付款超20亿美元,按照当前趋势,全年交易规模极有可能突破历史纪录。与2020—2024年相比,这一数据呈现出爆发式增长态势。彼时,BD交易总金额从92亿美元攀升至523亿美元,首付款总额也从6亿美元增长到41亿美元。创新药领域的这种价值重估,在二级市场获得了积极反馈。自...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.